Dr Rachael Dickman obtained her PhD from UCL in 2018 under the supervision of Professor Alethea Tabor. Following postdoctoral research with Professor Máté Erdélyi at Uppsala University, Sweden, she returned to the Department of Chemistry at UCL as an EPSRC Doctoral Prize Fellow to work with Professor Stefan Howorka and Professor Alethea Tabor. In 2020, Rachael joined the School of Pharmacy as Lecturer in Drug Discovery. Her research aims to develop new peptide drugs to treat infections and diseases. A primary interest of her research group is seeking to address antibiotic resistance using antimicrobial compounds produced by nature. This involves the solid-phase synthesis of complex cyclic peptides and their analogues, and studying their structure and mechanism of action using a suite of NMR and biophysical methods. To enable these synthetic efforts, she is also interested in developing novel synthetic routes to the unusual amino acids found in naturally-occurring antimicrobial peptides. Other applications her group is currently working on include peptide treatments for neurodegeneration as a result of injury or disease.